NEW YORK ( TheStreet) --

STOCK COMMENTS / EPS CHANGES

Baxter International ( BAX) is upgraded to buy at TheStreet Ratings.

Brinker ( EAT) numbers raised at UBS. Shares of EAT now seen reaching $30. Estimates also increased on positive SSS. Buy rating.

Expedia ( EXPE) numbers raised at UBS. Shares of EXPE now seen reaching $33. Estimates also increased after TipAdvisor spin off. Neutral rating.

Mead Johnson Nutrition ( MJN) numbers lowered at Goldman Sachs. Shares of MJN now seen reaching $74. Estimates also lowered on product safety fears. Neutral rating.

Everest Re ( RE) numbers lowered at UBS. Shares of RE now seen reaching $105. Estimates also lowered on Thailand floods. Buy rating.

Salix Pharmaceuticals numbers raised at Goldman Sachs. Shares of SLXP now seen reaching $46. Estimates also raised on positive Phase III data. Neutral rating.

United Continental ( UAL) estimates lowered at UBS through 2012. Company guides down. Buy rating and $35 price target.

Walgreen ( WAG) numbers lowered at Jefferies. Shares of WAG now seen reaching $34. Estimates also lowered on ongoing uncertainty surrounding the ESRX contract. Hold rating.

>To submit a news tip, email: tips@thestreet.com.

RELATED STORIES:


Follow TheStreet on Twitter and become a fan on Facebook.



This article was written by a staff member of RealMoney.com.